The Texas Children’s Hospital (TCH) and Baylor College of Medicine (BCM) announced that Corbevax, a protein subunit Covid vaccine, has received approval from the Drugs Controller General of India (DCGI) to launch it in India. The initial construct and production process of the vaccine antigen was developed at TCH’s Centre for Vaccine Development.
Buy Prime Test Series for all Banking, SSC, Insurance & other exams
As Corbevax has been granted emergency use authorisation in India, Professor Peter Hotez said, “given the urgency, Corbevax will be helpful not only for India but globally as most of the African continent, neighbouring countries around India remain largely unvaccinated.” Emergency use authorisation of Corbevax in India for adults 18 and older will have a great pediatric profile because parents have been giving the same technology (as in vaccine) to their kids for decades.
Important takeaways for all competitive exams:
In a landmark move to improve emergency healthcare access and reduce road accident fatalities, the…
China extended its supremacy in world badminton by clinching the Sudirman Cup 2025, defeating South…
On May 5, 2025, Shri Prakash Magdum, a seasoned Indian Information Service (IIS) officer of…
In a significant stride toward strengthening India's maritime defence capabilities, the Defence Research and Development…
India improved its rank to 130 out of 193 countries on the Human Development Index…
In a significant political development, Yemen's Presidential Leadership Council (PLC) appointed Salem Saleh Bin Braik,…
![](data:image/svg+xml;charset=utf-8,<svg height="171px" width="300px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
![](data:image/svg+xml;charset=utf-8,<svg height="34px" width="156px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
![](data:image/svg+xml;charset=utf-8,<svg height="218px" width="300px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
